ARA-290 (15mg)

What Is ARA 290?

ARA 290, also known as cibinetide, is a synthetic peptide based on a small region of erythropoietin (EPO), a naturally occurring hormone involved in red blood cell production. Researchers developed it to investigate some of EPO’s proposed tissue-protective and inflammation-modulating effects while aiming to avoid its stimulation of red blood cell production. ARA 290 is therefore distinct from EPO itself, but its biological effects and potential applications remain under investigation.

The peptide is commonly described in scientific literature as an 11-amino-acid compound. It has been studied in laboratory and early-stage clinical research, including research into nerve-related conditions and inflammation. These studies explore possible biological activity; they do not establish ARA 290 as a proven treatment or confirm that it is safe or effective for general use.

How It Is Studied

Researchers have proposed that ARA 290 may interact with a tissue-protective signaling pathway sometimes called the innate repair receptor. This pathway is associated with cellular responses to injury and inflammation. The proposed receptor activity differs from EPO’s well-known role in red blood cell formation, which is why the peptide has attracted scientific interest. However, the precise mechanisms, relevance in different tissues, and significance for human health are still being investigated.

Research findings should be interpreted cautiously. Results from laboratory models or small clinical studies may not predict outcomes in larger, well-controlled trials. Evidence may also differ by condition, study design, and participant group. ARA 290 should not be presented as a substitute for established medical care, and claims about specific benefits require reliable clinical evidence.

Research Status and Important Considerations

ARA 290 is investigational and is not an approved medicine for routine diagnosis, treatment, or prevention of disease in many jurisdictions. Regulatory status can vary by location, so users should check applicable requirements. The existence of published research or clinical trials does not mean a peptide product has been authorized for therapeutic use.

Safety information remains limited compared with that available for approved medicines. Potential risks, interactions, appropriate use, and long-term effects may not be fully characterized. This description is for general information and is not medical advice. Anyone considering a peptide for a health-related purpose should consult a qualified healthcare professional rather than relying on product claims or research summaries.

Product Information

ARA 290 is best understood as a research-stage peptide of scientific interest, not as an established therapy. Buyers evaluating a product should review its stated identity, purity documentation, storage information, and applicable legal and safety requirements. Product quality and labeling can vary, and a certificate or analytical report does not demonstrate that a substance is suitable or approved for human use.

99%+ Purity, Third Party Tested

Independently verified by three separate certified laboratories. COAs available pre-purchase.

GMP Manufacturing Standards

Synthesized in USA-registered facilities following Good Manufacturing Practices. Full chain of custody documentation.

Best In Class Fulfillment

Same-day shipping on orders before 12 PM PT. Free standard domestic shipping on orders over $400.

Zero Fillers or Additives

Pure active compounds only. Independently verified composition for reliable in vitro studies.